| Name | Walgreens #3243 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 1301 S 5th St, Saint Charles, Missouri 63301 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (636) 946-6210 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
This is a sad day for millions of homebound and chronically ill older Americans and their loved ones. The Centers for Medicare & Medicaid Services decision to enforce regulations that require physicians to have face-to-face encounters with homebound patients to receive Medicare benefits is a mistake. These regulations were originally delayed due to serious concerns about physicians' readiness to comply with them and the drastic impact that it will have on seriously ill patients.
Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for ELIQUIS® (apixaban), an investigational compound for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
Arizona Gov. Jan Brewer won't say until January if her state will expand Medicaid. In the meantime, advocates worry about whether health care for kids in Texas could be cut.
In the latest issue of the renowned scientific journal "Nature" researchers from the universities of Freiburg and Basel report on their discovery of previously unknown subunits of the GABAB receptors in the central nervous system. GABAB receptors are transmembrane proteins in nerve cells which are of fundamental significance for the functioning of the brain and have great therapeutical and pharmaceutical importance.
› Verified 6 days ago
| NPI Number | 1649285883 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #03243 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1301 S 5th St, Saint Charles, MO 63301 |
| Phone Number | 636-946-6210 |
News Archive
This is a sad day for millions of homebound and chronically ill older Americans and their loved ones. The Centers for Medicare & Medicaid Services decision to enforce regulations that require physicians to have face-to-face encounters with homebound patients to receive Medicare benefits is a mistake. These regulations were originally delayed due to serious concerns about physicians' readiness to comply with them and the drastic impact that it will have on seriously ill patients.
Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for ELIQUIS® (apixaban), an investigational compound for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
Arizona Gov. Jan Brewer won't say until January if her state will expand Medicaid. In the meantime, advocates worry about whether health care for kids in Texas could be cut.
In the latest issue of the renowned scientific journal "Nature" researchers from the universities of Freiburg and Basel report on their discovery of previously unknown subunits of the GABAB receptors in the central nervous system. GABAB receptors are transmembrane proteins in nerve cells which are of fundamental significance for the functioning of the brain and have great therapeutical and pharmaceutical importance.
› Verified 6 days ago
News Archive
This is a sad day for millions of homebound and chronically ill older Americans and their loved ones. The Centers for Medicare & Medicaid Services decision to enforce regulations that require physicians to have face-to-face encounters with homebound patients to receive Medicare benefits is a mistake. These regulations were originally delayed due to serious concerns about physicians' readiness to comply with them and the drastic impact that it will have on seriously ill patients.
Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for ELIQUIS® (apixaban), an investigational compound for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
Arizona Gov. Jan Brewer won't say until January if her state will expand Medicaid. In the meantime, advocates worry about whether health care for kids in Texas could be cut.
In the latest issue of the renowned scientific journal "Nature" researchers from the universities of Freiburg and Basel report on their discovery of previously unknown subunits of the GABAB receptors in the central nervous system. GABAB receptors are transmembrane proteins in nerve cells which are of fundamental significance for the functioning of the brain and have great therapeutical and pharmaceutical importance.
› Verified 6 days ago
3d Stability, Llc Type: Prosthetic/Orthotic Supplier Location: 25 Jason Ct, Saint Charles, Missouri 63304 Phone: (314) 256-9953 | |
Abchiropractic Family Type: Medicare Supplier Location: 2201 1st Capitol Dr, Saint Charles, Missouri 63301 Phone: (636) 916-0660 | |
Clarkson Eyecare Type: Medicare Supplier Location: 2121 Zumbehl Rd, Saint Charles, Missouri 63303 Phone: (636) 949-2906 | |
Clarkson Optometry Inc Type: Medicare Supplier Location: 6157 Mid Rivers Mall Dr, Saint Charles, Missouri 63304 Phone: (636) 926-3647 | |
Dierbergs Bogey Hills Pharmacy Type: Pharmacy Location: 2021 Zumbehl Rd, Saint Charles, Missouri 63303 Phone: (636) 947-0929 |